206. 脆弱Ｘ症候群 Fragile X syndrome Clinical trials / Disease details
臨床試験数 : 104 / 薬物数 : 87 - (DrugBank : 32) / 標的遺伝子数 : 54 - 標的パスウェイ数 : 79
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04308954 (ClinicalTrials.gov) | November 1, 2016 | 11/3/2020 | Neuroimaging GABA Physiology in Fragile X Syndrome | Cross-Species Multi-Modal Neuroimaging to Investigate GABA Physiology in Fragile X Syndrome | Fragile X Syndrome (FXS);Idiopathic Intellectual Developmental Disorder (IDD) | Drug: [18F]flumazenil | Stanford University | NULL | Terminated | 18 Years | 30 Years | Male | 17 | Phase 1 | United States |